The protein domain is probably the most ubiquitously affected in disease, response and
recovery, and therefore proteomics holds special promise for biomarker discovery in …

Inflammatory bowel disease (IBD) is a chronic relapsing/remitting inflammatory illness of the
gastrointestinal tract of unknown aetiology. Despite recent advances in decoding the …

Molecular biomarkers in blood are needed to aid the early diagnosis and clinical
assessment of glioblastoma (GBM). Here, in order to identify biomarker candidates in …

Around a 20–30% of inflammatory bowel disease (IBD) patients are diagnosed before they
are 18 years old. Anti-TNF drugs can induce and maintain remission in IBD, however, up to …

Inflammatory bowel diseases (IBD) are systemic immune-mediated conditions with
predilection for the gastrointestinal tract and include Crohn's disease and ulcerative colitis …

Recently, the field of proteomics has rapidly expanded in its application towards clinical
research with objectives ranging from elucidating disease pathogenesis to discovering …

Background: Up to 30% of patients with pediatric inflammatory bowel disease (IBD) do not
respond to anti-Tumor Necrosis Factor (anti-TNF) therapy. The aim of this study was to …

Background: To date, the elucidation of serum protein alterations in male breast cancer
(MBC) has not been extensively studied, due to the rarity of the disease. Materials and …

Background The molecular aetiology of inflammatory bowel disease [IBD] and its two
subtypes, ulcerative colitis [UC] and Crohn's disease [CD], have been carefully investigated …

Aging is associated with loss of muscle mass and strength that leads to a condition termed
sarcopenia. Impaired conditions, morbidity, and malnutrition are the factors of devaluation of …